Abstract
Venomous organisms are equipped with “venom,” which is injected through specialized devices (spines, fangs, stingers, hypostomes, spurs, harpoons) that help in the acquisition of prey and its digestion. The venom also serves as a defensive armament in protecting itself against the predators and aggressors. The diverse and synergistically acting cocktail of biologically active molecules of the venoms have been evolved with precise function to intervene in the biological systems of the prey/victims, thus helping in acquisition and its subsequent digestion. Although the potential role of many of the major principal constituents of venom in envenomation has been well documented, there is lack of information on the functional significance on the near ubiquitous distribution of purines and its endogenous (prey tissue) release-related enzymes in the venom of the venomous organisms. Purines acting via purinergic receptors are known to act as multitoxin and are known to be a central component of envenomation strategies, thus exemplifying the involvement of purinergic signaling in envenomation (immobilization and digestion). This work attempts to give an insight into the existence of purinergic signaling in envenomation strategies of venomous organisms. The work also explains how injecting exogenous (venom) nucleosides and releasing endogenous (prey tissue) nucleosides with venom enzymes are of complementary envenomation strategies. Further, it focuses on the recent experimental evidence in support of purinergic signaling in envenomation and highlights the importance of estimation of the physiological concentration of purines injected or released (in prey tissue) by action of venom enzymes for the establishment of purinergic signaling during envenomation.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Aird SD. Ophidian envenomation strategies and the role of purines. Toxicon. 2002;40:335–93.
Aird SD. Taxonomic distribution and quantitative analysis of free purine and pyrimidine nucleosides in snake venoms. Comparative biochemistry and physiology. Part B Biochem Mol Biol. 2005;140:109–26.
Aird SD. The role of purine and pyrimidine nucleosides in snake venoms. In: Mackessy SP, editor. Handbook of venoms and toxins of reptiles. Boca Raton: CRC Press/Taylor and Francis; 2010. p. 393–422.
Alape-Giron A, Sanz L, Escolano J, et al. Snake venomics of the lance head pitviper Bothrops asper: geographic, individual, and ontogenetic variations. J Proteome Res. 2008;7:3556–71.
Arrigoni E, Chamberlin NL, Saper CB, McCarley RW. Adenosine inhibits basal forebrain cholinergic and noncholinergic neurons in vitro. Neuroscience. 2006;140(2):403–13.
Barraco RA, Coffin VL, Altman HJ, Phillips JW. Central effects of adenosine analogs on locomotor activity in mice and antagonism of caffeine. Brain Res. 1983;272:392–5.
Bernheimer AW, Rudy B. Interactions between membranes and cytolytic peptides. Biochim Biophys Acta. 1986;864:123–41.
Born GV, Honour AJ, Mitchell JR. Inhibition by adenosine and by 2-chloroadenosine of the formation and embolization of platelet thrombi. Nature. 1964;202:761–5.
Burnstock G. Purinergic signalling–an overview. Novartis Found Symp. 2006;276:26–48.
Caccin P, Pellegatti P, Fernandez J, Vono M, Cintra-Francischinelli M, Lomonte B, Gutiérrez JM, Di Virgilio F, Montecucco C. Why myotoxin-containing snake venoms possess powerful nucleotidases? Biochem Biophys Res Commun. 2013;430(4):1289–93.
Castrop H. Mediators of tubuloglomerular feedback regulation of glomerular filtration: ATP and adenosine. Acta Physiol (Oxf). 2007;189:3–14.
Chippaux JP, Williams V, White J. Snake venom variability: methods of study, results and interpretation. Toxicon. 1991;29:1279–303.
Daltry JC, Wuster W, Thorpe RS. Diet and snake venom evolution. Nature. 1996;379:537–40.
Dhananjaya BL, D’Souza CJ. The pharmacological role of nucleotidases in snake venoms. Cell Biochem Funct. 2010;28:171–7.
Dhananjaya BL, Vishwanath BS, D’Souza CJ. Snake venom nucleases, nucleotidases and phosphomonoesterases. In: Mackessy SP, editor. Handbook of venoms and toxins of reptiles. Boca Raton: CRC Press/Taylor and Francis; 2010. p. 155–72.
Drury AN, Szent-Gyfrgyi A. The physiological activity of adenine compounds with especial reference to their action upon mammalian heart. J Physiol Lond. 1929;68:213–37.
Dunwiddie TV, Masino SA. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci. 2001;24:31–55.
Dunwiddie TV, Worth T. Sedative and anticonvulsant effects of adenosine analogs in mouse and rat. J Pharmacol Exp Ther. 1982;220:70–6.
Fan M, Jamal MS. Role of adenosine in airway inflammation in an allergic mouse model of asthma. Int Immunopharmacol. 2006;6(1):36–45.
Fischer FG, Dorfel H. Adenosine in Gift der puffotter Bitis arietans (schlangengifte, I). Hoppe-Seyler’s Z Phy Chem. 1954;296:232–8.
Girish KS, Kemparaju K. Overlooked issues of snakebite management: time for strategic approach. Curr Top Med Chem. 2011;11(20):2494–508.
Graham RL, McClean S, O’Kane EJ, Theakston D, Shaw C. Adenosine in the venoms from viperinae snakes of the genus Bitis: identification and quantitation using LC/MS and CE/MS. Biochem Biophys Res Commun. 2005;333(1):88–94.
Hargreaves MB, Stoggall SM, Collis MG. Evidence that the adenosine receptor mediating relaxation in dog lateral saphenous vein and guinea-pig aorta is of the A2B subtype. Br J Pharmacol. 1991;102:198.
Jain N, Kemp N, Adeyeno O, Buchanan P, Stone TW. Anxiolytic activity of adenosine receptor activation in mice. Br J Pharmacol. 1995;116:2127–33.
Ko KR, Ngai AC, Winn HR. Role of adenosine in the regulation of regional cerebral blood flow in sensory cortex. Am J Physiol. 1990;259(6 Pt 2):H1703–8.
Lo WC, Jan CR, Wu SN, Tseng CJ. Cardiovascular effects of nitric oxide and adenosine in the nucleus tractus solitarii of rats. Hypertension. 1998;32(6):1034–8.
Lumsden NG, Fry BG, Ventura S, Kini RM, Hodgson WC. The in vitro and in vivo pharmacological activity of Boiga dendrophila (mangrove catsnake) venom. Auton Autacoid Pharmacol. 2004;24:107–13.
Ma D, Armugam A, Jeyaseelan K. Cytotoxic potency of cardiotoxin from Naja sputatrix: development of a new cytolytic assay. Biochem J. 2002;366:35–43.
Navarro JF, Romero C, Maldonado E. Effects of N6-cyclohexyl adenosine (CHA) on isolation-induced aggression in male mice. Methods Find Exp Clin Pharmacol. 2000;22(1):43–6.
Nikodijevic O, Sarges R, Daly JW, Jacobson KA. Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonism. J Pharmacol Exp Ther. 1991;259:286–94.
Nunez CE, Angulo Y, Lomonte B. Identification of the myotoxic site of the Lys49 phospholipase A(2) from Agkistrodon piscivorus piscivorus snake venom: synthetic C-terminal peptides from Lys49, but not from Asp49 myotoxins, exert membrane-damaging activities. Toxicon. 2001;39:1587–94.
Olsson RA, Pearson JD. Cardiovascular purinoreceptors. Physiol Rev. 1990;70:761–845.
Ownby CL, Bjarnason J, Tu AT. Hemorrhagic toxins from rattlesnake (Crotalus atrox) venom. Pathogenesis of hemorrhage induced by three purified toxins. Am J Pathol. 1978;93:201–18.
Palmour RM, Lipowski CJ, Simon CK, Ervin FR. Adenosine analogs inhibit fighting in isolated male mice. Life Sci. 1989;44:1293–301.
Radulovacki M, Virus RM, Rapoza D, Crane RA. A comparison of the dose response effects of pyrimidine ribonucleosides and adenosine on sleep in rats. Psychopharmacology (Berl). 1985;87(2):136–40.
Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 1998;50:413–92.
Ramkumar V, Stiles GL, Beaven MA, Ali H. The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem. 1993;268:16887–90.
Redman RS, Silinsky EM. A selective adenosine antagonist (8-cyclopentyl-1,3-dipropylxanthine) eliminates both neuromuscular depression and the action of exogenous adenosine by an effect on A1 receptors. Mol Pharmacol. 1993;44:835–40.
Sarda N, Gharib A, Coindet J, Pacheco H, Jouvet M. Possible involvement of the S-adenosyl-l-homocysteine metabolites, adenosine and l-homocysteine, in sleep in rats. Neurosci Lett. 1986;66(3):287–92.
Sawynok J. Adenosine receptor activation and nociception. Eur J Pharmacol. 1998;347:1–11.
Sawynok J. Adenosine and ATP receptors. Handb Exp Pharmacol. 2007;177:309–28.
Sawynok J, Zarrindast MR, Reid AR, Doak GJ. Adenosine A3 receptor activation produces nociceptive behaviour and edema by release of histamine and 5-hydroxytryptamine. Eur J Pharmacol. 1997;333:1–7.
Sawynok J, Reid A, Liu XJ. Involvement of mast cells, sensory afferents and sympathetic mechanisms in paw oedema induced by adenosine A(1) and A(2B/3) receptor agonists. Eur J Pharmacol. 2000;395(1):47–50.
Seligmann C, Kupatt C, Becker BF, Zahler S, Beblo S. Adenosine endogenously released during early reperfusion mitigates postischemic myocardial dysfunction by inhibiting platelet adhesion. J Cardiovasc Pharmacol. 1998;32:156–63.
Silinsky EM. Adenosine decreases both presynaptic calcium currents and neurotransmitter release at the mouse neuromuscular junction. J Physiol. 2004;558(Pt 2):389–401.
Sobrevia L, Yudilevich DL, Mann GE. Activation of A2-purinoreceptors by adenosine stimulates l-arginine transport (system y+) and nitric oxide synthesis in human fetal endothelial cells. J Physiol. 1997;499(Pt 1):135–40.
Tilley SL, Wagoner VA, Salvatore CA, Jacobson MA, Koller BH. Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. J Clin Invest. 2000;105:361–7.
Winsky L, Harvey JA. Retardation of associative learning in the rabbit by an adenosine analog as measured by classical conditioning of the nictitating membrane response. J Neurosci. 1986;6:2684–90.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Dhananjaya, B.L., D’Souza, C.J.M. (2016). Purinergic Mechanisms of Prey Acquisition by Venomous Organisms. In: Gopalakrishnakone, P., Calvete, J. (eds) Venom Genomics and Proteomics. Toxinology. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6416-3_1
Download citation
DOI: https://doi.org/10.1007/978-94-007-6416-3_1
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6415-6
Online ISBN: 978-94-007-6416-3
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences